Related Experiment Video
Updated: Feb 28, 2026

Cell Population Analyses During Skin Carcinogenesis
Published on: August 21, 2013
From basal cell carcinoma morphogenesis to the alopecia induced by hedgehog inhibitors: connecting the dots
C Dessinioti1, C Antoniou1, A J Stratigos1
1Dermato-Oncology Unit, First Department of Dermatology, University of Athens, Andreas Syggros Hospital, Athens, Greece.
Abstract:
The deciphering of the hedgehog (Hh) signalling pathway implicated in the tumorigenesis of basal cell carcinoma (BCC) led to the development of targeted drug therapies, the Hh pathway inhibitors (HPIs) vismodegib and sonidegib. In the skin, physiological Hh signalling is activated in growing hair follicles (HFs), where it is required for proliferation of the epithelium of HFs during morphogenesis and for their postnatal growth. The effects of HPI treatment leading to the regression of BCC and the development of alopecia underpin the central role of the Hh pathway in BCC formation, as well as hair cycling. Given the fact that BCC is a follicular-driven tumour, it is a fine tuning of events that regulate hair cycling that may drive towards the formation of benign follicular hamartomas or malignant BCC neoplasms. Wnt/β-catenin signalling interacts with the Hh signalling during HF morphogenesis, normal hair cycling and BCC development. The aim of this review is to present how key molecular events implicated in Hh pathway crosstalk in the HF are also involved in BCC pathogenesis and result in the alopecia developed by HPI treatment.
Insights
Hedgehog (Hh) pathway inhibitors treat basal cell carcinoma (BCC) by targeting hair follicle growth. Understanding Hh pathway crosstalk in hair follicles is key to treating BCC and preventing HPI-induced alopecia.
Area of Science:
- Dermatology
- Oncology
- Molecular Biology
Background:
- Basal cell carcinoma (BCC) tumorigenesis is linked to the hedgehog (Hh) signalling pathway.
- Hh signalling is crucial for hair follicle (HF) development and hair cycling.
- Hh pathway inhibitors (HPIs) like vismodegib and sonidegib are effective BCC therapies but can cause alopecia.
Purpose of the Study:
- To review the molecular events of Hh pathway crosstalk in hair follicles.
- To elucidate the role of these events in BCC pathogenesis.
- To explain HPI-induced alopecia.
Main Methods:
- Literature review of Hh signalling in skin biology and BCC.
- Analysis of molecular interactions between Hh and Wnt/β-catenin pathways.
- Examination of HPI effects on hair follicles.
Main Results:
- Hh pathway is central to both HF cycling and BCC development.
- Wnt/β-catenin signalling interacts with Hh signalling in HF morphogenesis and BCC.
- HPI treatment disrupts Hh signalling, leading to BCC regression and alopecia.
Conclusions:
- Fine-tuning of hair cycling events by Hh signalling can lead to benign or malignant follicular neoplasms.
- Hh pathway crosstalk in HFs is a critical factor in BCC pathogenesis.
- Understanding this crosstalk is essential for managing HPI side effects like alopecia.
Related Concept Videos
Hedgehog Signaling Pathway
Multipotency and Niche of Bulge Stem Cell
Accessory Structures of the Skin: Hair Growth and Types
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Regulation of Angiogenesis and Blood Supply

